Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results
Barve, M, Grosen, E.A, Fine, B.A, Heffernan, T.P, Matthews, C.M, Stringer, C.A, Koon, E.C, Goodman, H.M, Fleming, E.L, DeMars, L.R, Bergman, M.S, Senzer, N, Nemunaitis, J
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
100 (PB088): KRASmulti inhibitor BI 3706674 shows efficacy in KRAS-driven preclinical models of cancer that supports clinical testing in patients with tumors harboring KRASG12V mutations and KRAS wild-type amplifications
Tedeschi, A., Peng, D.H., Schischlik-Siegl, F., Schaaf, O., Gerlach, D., Rocchetti, F., Popow, J., Broeker, J., Wunberg, T., Boghossian, A.S., Rees, M.G., Ronan, M.M., Roth, J.A., Williams, M., Vellano, C., Marszalek, J.R., Heffernan, T.P., Pearson, M., Kraut, N., Dorothea, R.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
126 (PB114): A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Jung, P., Glaser, S.P., Han, J., Popa, A., Pisarsky, L., Feng, N., Geyer, A., Haderk, F., Alpar, D., Bristow, C., Drobits-Handl, B., Kasturirangan, S., Trapani, F., Marszalek, J.R., Tontsch-Grunt, U., Pearson, M., Heffernan, T.P., Kraut, N., Vellano, C.P., García-Martínez, J.M.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
MEKi-based combination strategies for targeting KRAS-driven cancer
Kostyrko, K., Hinkel, M., Traexler, P.E., Arnold, D., Melo-Zainzinger, G., Gerlach, D., Ruzicka, R., Jacob, R., Baum, A., Lu, H., Vellano, C.P., Marszalek, J.R., Heffernan, T.P., Tontsch-Grunt, U., Hofmann, M.H.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome
Wardwell-Ozgo, J, Dogruluk, T, Gifford, A, Zhang, Y, Heffernan, T P, van Doorn, R, Creighton, C J, Chin, L, Scott, K L
Published in Oncogene (20.02.2014)
Published in Oncogene (20.02.2014)
Get full text
Journal Article
Vertical pathway inhibition with a SOS1::KRAS inhibitor enhances the efficacy of KRAS G12C inhibitors, delays feedback resistance and demonstrates durable response
Savarese, F., Gmachl, M., Federico, L., Trapani, F., Gerlach, D., Daniele, J., Feng, N., Bristow, C.A., Machado, A., Huang, J., Rudolph, D., Waizenegger, I., Ramharter, J., Vellano, C.P., Petronczki, M., Marszalek, J.R., Heffernan, T.P., McConnell, D.B., Kraut, N., Hofmann, M.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article